Trial Search Results

Global Utilization And Registry Database for Improved heArt preservatioN

The primary objective of this study is to collect real-world clinical performance data to assess the clinical outcomes of patients receiving heart transplants using donor hearts transported via the SherpaPak CTS System. These results will be compared to outcomes of retrospective patients whose hearts were transported with the previous standard method.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Paragonix Technologies

Stanford Investigator(s):

Intervention(s):

  • Device: SherpaPak Cardiac Transport System

Eligibility


Inclusion Criteria:

   - Donor and donor hearts matched to the prospective recipient based upon institutional
   medical practice

   - Registered male or female primary heart transplant candidates including pediatric
   candidates

Exclusion Criteria:

   - Donor and donor hearts that do not meet institutional clinical requirements for
   transplantation

   - When safe connection with the aorta cannot be made, e.g., due to lack of enough length
   of the aortic root

   - Patients who are incarcerated persons (prisoners)

   - Patients who have had a previous organ transplant

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting